HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors

• Published in: Cell death & disease 2020-09, Vol.11 (8), p.715, Article 715
• Main Authors: Fang, Chieh-Ting, Kuo, Hsiao-Hui, Hsu, Shao-Chun, Yih, Ling-Huei
• Format: Article
• Language: English
• Subjects: 14/19; 631/80/128/1923; 631/80/470/1981; 631/80/641/1655; Antibodies; Antineoplastic Agents - metabolism; Antineoplastic drugs; Antitumor agents; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Culture; Cell Cycle Proteins - metabolism; Cell Proliferation; Cytotoxicity; Drug resistance; Drug Resistance, Neoplasm - physiology; Heat shock proteins; HeLa Cells; HSP70 Heat-Shock Proteins - metabolism; HSP70 Heat-Shock Proteins - physiology; Hsp70 protein; Humans; Immunology; Kinases; Kinesin; Kinesin - metabolism; Life Sciences; Localization; Microtubule-Associated Proteins - metabolism; Microtubules - metabolism; Mitosis - physiology; Proteins; Spindle Apparatus - metabolism
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-020-02919-7

The heat shock protein 70 (HSP70) is a conserved molecular chaperone and proteostasis regulator that protects cells from pharmacological stress and promotes drug resistance in cancer cells. In this study, we found that HSP70 may promote resistance to anticancer drugs that target the mitotic kinesin, Eg5, which is essential for assembly and maintenance of the mitotic spindle and cell proliferation. Our data show that loss of HSP70 activity enhances Eg5 inhibitor-induced cytotoxicity and spindle abnormalities. Furthermore, HSP70 colocalizes with Eg5 in the mitotic spindle, and inhibition of HSP70 disrupts this colocalization. Inhibition or depletion of HSP70 also causes Eg5 to accumulate at the spindle pole, altering microtubule dynamics and leading to chromosome misalignment. Using ground state depletion microscopy followed by individual molecule return (GSDIM), we found that HSP70 inhibition reduces the size of Eg5 ensembles and prevents their localization to the inter-polar region of the spindle. In addition, bis(maleimido)hexane-mediated protein-protein crosslinking and proximity ligation assays revealed that HSP70 inhibition deregulates the interaction between Eg5 tetramers and TPX2 at the spindle pole, leading to their accumulation in high-molecular-weight complexes. Finally, we showed that the passive substrate-binding activity of HSP70 is required for appropriate Eg5 distribution and function. Together, our results show that HSP70 substrate-binding activity may regulate proper assembly of Eg5 ensembles and Eg5-TPX2 complexes to modulate mitotic distribution/function of Eg5. Thus, HSP70 inhibition may sensitize cancer cells to Eg5 inhibitor-induced cytotoxicity.